Skip to main content

Table 1 Overview of the number of animals, age at inclusion, sex and weight at vaccination or injection, per treatment group

From: A field efficacy and safety trial in the Netherlands in pigs vaccinated at 3 weeks of age with a ready-to-use porcine circovirus type 2 and Mycoplasma hyopneumoniae combined vaccine

 

Control (N = 276)

FLEX (N = 267)

PCVM (N = 269)

Overall (N = 812)

Age (days)

 16

3 (1.1%)

3 (1.1%)

2 (0.7%)

8 (1.0%)

 17

39 (14.1%)

35 (13.1%)

40 (14.9%)

114 (14.0%)

 18

44 (15.9%)

42 (15.7%)

43 (16.0%)

129 (15.9%)

 19

28 (10.1%)

27 (10.1%)

28 (10.4%)

83 (10.2%)

 20

3 (1.1%)

3 (1.1%)

3 (1.1%)

9 (1.1%)

 21

15 (5.4%)

16 (6.0%)

14 (5.2%)

45 (5.5%)

 22

26 (9.4%)

25 (9.4%)

27 (10.0%)

78 (9.6%)

 23

61 (22.1%)

58 (21.7%)

60 (22.3%)

179 (22.0%)

 24

32 (11.6%)

33 (12.4%)

27 (10.0%)

92 (11.3%)

 25

22 (8.0%)

22 (8.2%)

22 (8.2%)

66 (8.1%)

 26

3 (1.1%)

3 (1.1%)

3 (1.1%)

9 (1.1%)

Gender

 Female

144 (52.2%)

136 (50.9%)

122 (45.4%)

402 (49.5%)

 Male

132 (47.8%)

131 (49.1%)

147 (54.6%)

410 (50.5%)

Weight (kg)

 N

276

267

269

812

 Mean

5.6

5.6

5.7

5.6

 Standard deviation

1.54

1.56

1.57

1.56

 Minimum

1.6

1.7

1.9

1.6

 Maximum

10.2

10.2

10.0

10.2